Projektbeschreibung
Ein innovatives Dekontaminationsprodukt gegen COVID-19
Die meisten Dekontaminationsmittel gegen Krankheitserreger wie COVID-19 oder das Grippevirus basieren auf Chemikalien, die nicht oft auf der Haut angewendet werden können, da sie zu gesundheitlichen Komplikationen führen können. Das EU-finanzierte Projekt ABwipe entwickelt ein einzigartiges Produkt, das den Mechanismus der Krankheitserregerbindung nutzt. Es baut auf einer Zellulosematrix auf und enthält Kohlenhydrat-Protein-Binder mit einer starken Affinität für pandemische Viren wie das Grippe- und Coronavirus. Neben seiner desinfizierenden Fähigkeit, durch das möglicherweise die Infektionsverbreitung gebremst werden kann, kann das ABwipe-Material in der Forensik und der Diagnostik für die Identifizierung von Krankheitserregern eingesetzt werden.
Ziel
Infectious diseases, such as COVID-19, plague, Ebola, SARS and flu, caused by biological agents, are among the most serious and least predicted threats facing the global community. As we currently experience with the COVID-19 pandemic, bioagents can cause enormous societal and economic damage. Unlike, in the case of chemical, radiological or nuclear incidents, like e.g. in Chernobyl where people could not do much to stop the spread across Europe, in the case of the COVID-19 outbreak, public has a real power to reduce the impact by social distancing, respiratory etiquette, hand hygiene and decontamination in an attempt to flatten the curve.
Current decontamination solutions are suitable for hard surfaces but based on chemicals that cannot be used repeatedly on skin because they are harmful to humans, lead to health complications (hormonal imbalance, allergic reaction and dryness etc.) and damage the environment. There has been a lack of innovation in human-decontamination technologies over the decades and there is a clear need for technologies that can deliver safe, effective and immediate decontamination of human skin. The technological innovation of ABwipe offers a paradigm shift in decontamination.
ABwipe is a unique product, inspired by nature and exploiting the mechanism of pathogen binding. It is made up of a matrix material (cellulose fibres) with attached carbohydrate-protein binders, carefully selected with strong affinities for biothreat agents, including pandemic agents such as influenza and coronavirus. ABwipe not only decontaminates but also captures and contains biological agents. This is a significant capability that reduces the impact, impedes the spread of the infection and allows forensics and diagnostics to identify harmful agents. It is an effective, safer, better and fit for purpose solution for potentially devastating bioagent threat to the society, saving lives, restoring the health of victims and returning contaminated areas to a safe state
Wissenschaftliches Gebiet
- medical and health scienceshealth sciencesinfectious diseasesRNA virusesebola
- medical and health scienceshealth sciencespublic healthepidemiologypandemics
- medical and health scienceshealth sciencesinfectious diseasesRNA virusesinfluenza
- medical and health scienceshealth sciencesinfectious diseasesRNA virusescoronaviruses
Schlüsselbegriffe
Programm/Programme
Thema/Themen
Aufforderung zur Vorschlagseinreichung
Andere Projekte für diesen Aufruf anzeigenUnterauftrag
H2020-EIC-SMEInst-2018-2020-3
Finanzierungsplan
SME-2 - SME instrument phase 2Koordinator
Moycullen Galway
Irland
Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen).